Courtesy of Benzinga.
Slowing growth and lower margins are likely to put near-term pressure on Cognex Corporation (NASDAQ: CGNX), according to Goldman Sachs.
The Analyst
Joe Ritchie of Goldman Sachs downgraded Cognex from Buy to Neutral and lowered the stock’s 12-month price target from $78 to $55.
The Thesis
In the long run, Cognex will stand to benefit from technological adoption driven by automation tailwinds such as wage inflation, lack of skilled manufacturing workers and an aging factory installed base, Ritchie said in a Tuesday note.
“We continue to view CGNX as a high-quality franchise with best-in-class margins,” he said.
This year could prove to be one of transition year for the machine vision company, as opex growth is likely to exceed topline growth, putting pressure on margins, Ritchie said.
“Opex is likely to grow faster than sales as CGNX continues to invest in longer-term secular opportunities.”
Price Action
At the time of publication, Cognex shares were trading up 1.15 percent at $50.45.
Related Links:
5 Reasons Why Vuzix Is One Of Chardan Capital’s Top Picks In 2018
Benzinga’s Top Upgrades, Downgrades For April 10, 2018
Latest Ratings for CGNX
Date | Firm | Action | From | To |
---|---|---|---|---|
Apr 2018 | Goldman Sachs | Downgrades | Buy | Neutral |
Apr 2018 | JP Morgan | Upgrades | Underweight | Neutral |
Feb 2018 | Canaccord Genuity | Maintains | Hold | Hold |
View More Analyst Ratings for CGNX
View the Latest Analyst Ratings
Posted-In: Goldman Sachs Joe RitchieAnalyst Color Downgrades Price Target Analyst Ratings Best of Benzinga